The discovery broadens the known spectrum of this rare disorder, emphasizing the critical role of collaboration with patient ...

Akeso Pharmaceuticals and Summit Therapeutics have reported that their PD-1/VEGF bispecific antibody has met the primary ...

Both approaches eliminated or reduced apathy in the mice. Treating the mice with an IL-6 antibody similar to an existing FDA-approved drug for rheumatoid arthritis, an inflammatory condition ...